Esophageal Variceal Hemorrhage Diagnosis and Management

Clinical Presentation and Risk Factors

Black hematemesis (coffee-ground emesis) indicates upper gastrointestinal bleeding where blood has been exposed to gastric acid, producing the characteristic dark appearance 2
The presence of varicose veins in the extremities may be a clinical clue to systemic venous abnormalities and potential portal hypertension, as patients with portal hypertension commonly develop collateral circulation including esophageal varices 3, 4
Esophageal varices are present in patients when portal pressure exceeds 10 mmHg, and variceal hemorrhage occurs at a yearly rate of 5-15% with mortality of at least 20% at 6 weeks 3, 4
The American Association for the Study of Liver Diseases recommends that patients with esophageal varices should be screened for underlying liver disease 3

Esophagogastroduodenoscopy (EGD) is the gold standard for diagnosis and should be performed within 24 hours, as diagnostic and therapeutic success rates are highest within the first 36 hours of bleeding onset 3, 6
The American College of Gastroenterology recommends checking hemoglobin/hematocrit, coagulation studies, liver function tests, and platelet count to assess severity and identify underlying liver disease 7, 6

Transfuse packed red blood cells to maintain hemoglobin above 7 g/dL (or 9 g/dL if massive bleeding or cardiovascular comorbidities present) 6, 1
Avoid excessive fluid resuscitation as this may increase portal pressure and aggravate variceal bleeding, as recommended by the European Association for the Study of the Liver 8

Initiate vasoactive drugs (octreotide or terlipressin) immediately upon suspicion, before endoscopy, as recommended by the American Association for the Study of Liver Diseases 8
Perform endoscopic variceal ligation (EVL) during diagnostic endoscopy if varices are identified as the bleeding source, with a success rate of over 90% 8
Start high-dose proton pump inhibitor therapy following endoscopic intervention, as recommended by the American College of Gastroenterology 6
Consider nonselective beta-blockers (propranolol or nadolol) for secondary prophylaxis after acute bleeding is controlled, with a reduction in rebleeding risk of up to 50% 8